If 2020 was consumed by Covid Virus , the next year 2021 will be for Covid vaccination.
All over the world, billions of people are going to get vaccine.
Corona vaccination is one of the most anticipated events in every country. in coming weeks, multiple vaccines are likely to get regulatory approval.
However, while making a good vaccine was the difficult part, earning trust of public in vaccine is going to be another one. Especially the hurried development at Pandemic speed and lack of awareness about safety issues will be areas of concern.
The adverse events, which are unexpected medial problems that occur with drug treatments, are unavoidable part of any treatment, including vaccine science.
The system need to be in place to identify the causal relationship between vaccine agent and the adverse event. The objective criteria have to be in place to identify and treat, as the population to be vaccinated is also very large.
The main hurdles equally challenging will be sourcing, distributing and giving the actual vaccination doses.
The preparation for mammoth exercise will also be a herculean task. It may take months to get ready to supply and build the chains and preparation for this need to begin now.
A systematic approach needs to be ready, so that the process of vaccination gets on smoothly and quickly, as soon as the doses are available. For example, the need for transport vehicles and the storage facilities for billions of doses at distant places will be one of challenges.
It will take mammoth number of healthcare workers, who will vaccinate people at different towns and cities.
This exercise, if not done in a well-planned manner, could result in chaos. The failure to set up a system will not only result in suboptimal vaccination but also non uniform supplies. Maintaining the cold chain will be crucial for effectiveness.
People should get it based on needs rather than black marketing or money power. The issues which look insignificant like the financial complexity among various stake holders or customer clearances need to be settled first, as they may become significant hurdles for smooth distribution.
Most important would be to safeguard citizen’s faith in vaccine and clinical trials. As for the future science to develop, would require people’s co-operation, faith and participation.
Government regulators and Vaccine makers need to recognize the utmost importance of the communication about the true results of trials and effective communication with the public. The misinformation and distrust should not undermine the good work of medical science and advancements.